Literature DB >> 14566939

Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry.

Oner Ozdemir1, Yaddanapudi Ravindranath, Süreyya Savaşan.   

Abstract

BACKGROUND: In addition to (51)chromium release assay, flow cytometric methods have been described to assess in vitro cell-mediated cytotoxicity. In this report, we describe a new flow cytometric approach for determination of in vitro cell-mediated cytotoxicity utilizing three-color flow cytometric assay.
METHODS: This method is based on monoclonal antibody staining of either effector or target cells to evaluate cytotoxicity with increased accuracy by utilizing fluorospheres for calibration. The basic strategy involves labeling effector or target cells with a specific fluorescent-conjugated monoclonal antibody, in addition to staining with annexinV-FITC and propidium iodide to identify apoptotic/dead cells. The effector and target cell populations as well as conjugates were clearly and easily identified by this approach.
RESULTS: We obtained significant correlation between cytotoxicity calculated by this technique and (51)chromium release assay results. The integration of fluorospheres allowed us to determine the absolute number of events reflective of the cumulative cell death rather than a cross-sectional, percentage-based cytotoxicity assessment in the target cell population at the time of analysis.
CONCLUSIONS: This method provides additional advantages to other methods and enables the study of target cell fate in more detail, as well as providing a potential contribution to understanding the mechanisms of cell elimination. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566939     DOI: 10.1002/cyto.a.10081

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  11 in total

1.  Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.

Authors:  Alfredo Perales-Puchalt; Nikolaos Svoronos; Melanie R Rutkowski; Michael J Allegrezza; Amelia J Tesone; Kyle K Payne; Jayamanna Wickramasinghe; Jenny M Nguyen; Shane W O'Brien; Kiranmai Gumireddy; Qihong Huang; Mark G Cadungog; Denise C Connolly; Julia Tchou; Tyler J Curiel; Jose R Conejo-Garcia
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

2.  Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.

Authors:  Brenna E Swift; Brent A Williams; Yoko Kosaka; Xing-Hua Wang; Jeffrey A Medin; Sowmya Viswanathan; Joaquin Martinez-Lopez; Armand Keating
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

3.  Analysis of the intracellular role of galectins in cell growth and apoptosis.

Authors:  Daniel K Hsu; Ri-Yao Yang; Jun Saegusa; Fu-Tong Liu
Journal:  Methods Mol Biol       Date:  2015

4.  A randomized placebo-controlled trial of massage therapy on the immune system of preterm infants.

Authors:  Jocelyn Y Ang; Jorge L Lua; Ambika Mathur; Ronald Thomas; Basim I Asmar; Sureyya Savasan; Steven Buck; Michael Long; Seetha Shankaran
Journal:  Pediatrics       Date:  2012-11-12       Impact factor: 7.124

Review 5.  Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity.

Authors:  Stefan Kiesgen; John C Messinger; Navin K Chintala; Zachary Tano; Prasad S Adusumilli
Journal:  Nat Protoc       Date:  2021-02-15       Impact factor: 13.491

Review 6.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

7.  A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.

Authors:  G G Kim; V S Donnenberg; A D Donnenberg; W Gooding; T L Whiteside
Journal:  J Immunol Methods       Date:  2007-06-28       Impact factor: 2.303

8.  Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.

Authors:  Yaoyu Chen; Jinyun Chen; Jianjun Yu; Guizhi Yang; Emilia Temple; Fred Harbinski; Hui Gao; Christopher Wilson; Raymond Pagliarini; Wenlai Zhou
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

9.  A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers.

Authors:  Moein Dehbashi; Zohreh Hojati; Majid Motovali-Bashi; Mohamad Reza Ganjalikhany; William C Cho; Akihiro Shimosaka; Parnian Navabi; Mazdak Ganjalikhani-Hakemi
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

10.  In vitro characterization of arylhydrazones of active methylene derivatives.

Authors:  Suresh Palanivel; Anastasia Zhurina; Phuong Doan; Jerome G Chandraseelan; Vinoth Kumar Megraj Khandelwal; Fedor I Zubkov; Kamran T Mahmudov; Armando J L Pombeiro; Olli Yli-Harja; Meenakshisundaram Kandhavelu
Journal:  Saudi Pharm J       Date:  2018-01-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.